Biologics Contract Development and Manufacturing Organization (CDMO) - Global Market Outlook (2020-2028)
According to Stratistics MRC, the Global Biologics Contract Development and Manufacturing Organization (CDMO) Market is accounted for $9.93 billion in 2020 and is expected to reach $25.48 billion by 2028 growing at a CAGR of 12.5% during the forecast period. Rising number of pharmaceutical and biopharmaceutical companies in the emerging economies, high demand for novel therapeutics applications, and increasing demand for small molecules and biologics are the major factors propelling the market growth. However, stringent government regulations in the drug approval process and lack of investment are hampering the market growth.
Biologics production has mushroomed in recent years with massive investments from big bio-pharma and contract manufacturing alike. The increasing outsourcing trend by small and large pharmaceutical companies represents a promising opportunity for contract development and manufacturing organizations (CDMOs). As pharma shifts its focus to more research and development and less in-house manufacturing, CDMOs are well positioned to fill the gap between their clients and the patient. CDMOs give pharmaceutical and biologic manufacturers one of the most important assets in today’s fast-paced world. By outsourcing manufacturing processes, pharmaceutical and biologic manufacturers can free-up the internal resources required to prioritise internal capacities and enhance process efficiencies.
Based on product, the biologics segment is going to have a lucrative growth during the forecast period owing to the most successful therapeutic drug classes and attracting huge investment for the biologics industry. Since biologics have been dominating the human drug development because of their long-lasting effects and ability to precisely address the molecular causes of disease, the CDMOs are increasing in demand thereby escalating growth of the segment.
By geography, Asia Pacific is going to have a lucrative growth during the forecast period due to the growing number of pharmaceutical companies in emerging economies such as India and China. In particular, global companies are choosing India owing to the high production of biosimilars in the country. Moreover, the low cost of manufacturing activities and skilled labor are the major factors drivers of this market region.
Some of the key players profiled in the Biologics Contract Development and Manufacturing Organization (CDMO) Market include AbbVie Contract Manufacturing, AGC Biologics, Binex Co. Limited, Boehringer Ingelheim Group, Catalent Inc., Fujifilm Diosynth Biotechnologies USA Inc., JRS Pharma, Lonza Group, Parexel International Corporation, PRA Health Sciences, Rentschler Biotechnologies, Samsung Biologics, Sandoz Biopharmaceuticals (Novartis AG), Toyobo Co. Limited, and Wuxi Biologics.
Types Covered:
All the customers of this report will be entitled to receive one of the following free customization options:
Biologics production has mushroomed in recent years with massive investments from big bio-pharma and contract manufacturing alike. The increasing outsourcing trend by small and large pharmaceutical companies represents a promising opportunity for contract development and manufacturing organizations (CDMOs). As pharma shifts its focus to more research and development and less in-house manufacturing, CDMOs are well positioned to fill the gap between their clients and the patient. CDMOs give pharmaceutical and biologic manufacturers one of the most important assets in today’s fast-paced world. By outsourcing manufacturing processes, pharmaceutical and biologic manufacturers can free-up the internal resources required to prioritise internal capacities and enhance process efficiencies.
Based on product, the biologics segment is going to have a lucrative growth during the forecast period owing to the most successful therapeutic drug classes and attracting huge investment for the biologics industry. Since biologics have been dominating the human drug development because of their long-lasting effects and ability to precisely address the molecular causes of disease, the CDMOs are increasing in demand thereby escalating growth of the segment.
By geography, Asia Pacific is going to have a lucrative growth during the forecast period due to the growing number of pharmaceutical companies in emerging economies such as India and China. In particular, global companies are choosing India owing to the high production of biosimilars in the country. Moreover, the low cost of manufacturing activities and skilled labor are the major factors drivers of this market region.
Some of the key players profiled in the Biologics Contract Development and Manufacturing Organization (CDMO) Market include AbbVie Contract Manufacturing, AGC Biologics, Binex Co. Limited, Boehringer Ingelheim Group, Catalent Inc., Fujifilm Diosynth Biotechnologies USA Inc., JRS Pharma, Lonza Group, Parexel International Corporation, PRA Health Sciences, Rentschler Biotechnologies, Samsung Biologics, Sandoz Biopharmaceuticals (Novartis AG), Toyobo Co. Limited, and Wuxi Biologics.
Types Covered:
- Mammalian
- Non-mammalian (Microbial)
- Biologics
- Biosimilars
- Contract Manufacturing Organization (CMO)
- Contract Research Organization (CRO)
- Big Pharma
- Generic Pharma
- Small Pharma
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- Italy
- France
- Spain
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia
- New Zealand
- South Korea
- Rest of Asia Pacific
- South America
- Argentina
- Brazil
- Chile
- Rest of South America
- Middle East & Africa
- Saudi Arabia
- UAE
- Qatar
- South Africa
- Rest of Middle East & Africa
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2019, 2020, 2021, 2025, and 2028
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
All the customers of this report will be entitled to receive one of the following free customization options:
- Company Profiling
- Comprehensive profiling of additional market players (up to 3)
- SWOT Analysis of key players (up to 3)
- Regional Segmentation
- Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
- Competitive Benchmarking
- Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
1 EXECUTIVE SUMMARY
2 PREFACE
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 MARKET TREND ANALYSIS
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Application Analysis
3.8 Emerging Markets
3.9 Impact of Covid-19
4 PORTERS FIVE FORCE ANALYSIS
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 GLOBAL BIOLOGICS CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATION (CDMO) MARKET, BY TYPE
5.1 Introduction
5.2 Mammalian
5.3 Non-mammalian (Microbial)
6 GLOBAL BIOLOGICS CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATION (CDMO) MARKET, BY PRODUCT
6.1 Introduction
6.2 Biologics
6.2.1 Monoclonal (Diagnostic, Therapeutic, and Protein-based)
6.2.2 Recombinant Proteins
6.2.3 Antisense and Molecular Therapy
6.2.4 Vaccines
6.2.5 Other Biologics
6.3 Biosimilars
7 GLOBAL BIOLOGICS CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATION (CDMO) MARKET, BY SERVICE
7.1 Introduction
7.2 Contract Manufacturing Organization (CMO)
7.3 Contract Research Organization (CRO)
8 GLOBAL BIOLOGICS CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATION (CDMO) MARKET, BY APPLICATION
8.1 Introduction
8.2 Big Pharma
8.3 Generic Pharma
8.4 Small Pharma
9 GLOBAL BIOLOGICS CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATION (CDMO) MARKET, BY GEOGRAPHY
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 Italy
9.3.4 France
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 New Zealand
9.4.6 South Korea
9.4.7 Rest of Asia Pacific
9.5 South America
9.5.1 Argentina
9.5.2 Brazil
9.5.3 Chile
9.5.4 Rest of South America
9.6 Middle East & Africa
9.6.1 Saudi Arabia
9.6.2 UAE
9.6.3 Qatar
9.6.4 South Africa
9.6.5 Rest of Middle East & Africa
10 KEY DEVELOPMENTS
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies
11 COMPANY PROFILING
11.1 AbbVie Contract Manufacturing
11.2 AGC Biologics
11.3 Binex Co. Limited
11.4 Boehringer Ingelheim Group
11.5 Catalent Inc.
11.6 Fujifilm Diosynth Biotechnologies USA Inc.
11.7 JRS Pharma
11.8 Lonza Group
11.9 Parexel International Corporation
11.10 PRA Health Sciences
11.11 Rentschler Biotechnologies
11.12 Samsung Biologics
11.13 Sandoz Biopharmaceuticals (Novartis AG)
11.14 Toyobo Co. Limited
11.15 Wuxi Biologics
2 PREFACE
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 MARKET TREND ANALYSIS
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Application Analysis
3.8 Emerging Markets
3.9 Impact of Covid-19
4 PORTERS FIVE FORCE ANALYSIS
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 GLOBAL BIOLOGICS CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATION (CDMO) MARKET, BY TYPE
5.1 Introduction
5.2 Mammalian
5.3 Non-mammalian (Microbial)
6 GLOBAL BIOLOGICS CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATION (CDMO) MARKET, BY PRODUCT
6.1 Introduction
6.2 Biologics
6.2.1 Monoclonal (Diagnostic, Therapeutic, and Protein-based)
6.2.2 Recombinant Proteins
6.2.3 Antisense and Molecular Therapy
6.2.4 Vaccines
6.2.5 Other Biologics
6.3 Biosimilars
7 GLOBAL BIOLOGICS CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATION (CDMO) MARKET, BY SERVICE
7.1 Introduction
7.2 Contract Manufacturing Organization (CMO)
7.3 Contract Research Organization (CRO)
8 GLOBAL BIOLOGICS CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATION (CDMO) MARKET, BY APPLICATION
8.1 Introduction
8.2 Big Pharma
8.3 Generic Pharma
8.4 Small Pharma
9 GLOBAL BIOLOGICS CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATION (CDMO) MARKET, BY GEOGRAPHY
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 Italy
9.3.4 France
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 New Zealand
9.4.6 South Korea
9.4.7 Rest of Asia Pacific
9.5 South America
9.5.1 Argentina
9.5.2 Brazil
9.5.3 Chile
9.5.4 Rest of South America
9.6 Middle East & Africa
9.6.1 Saudi Arabia
9.6.2 UAE
9.6.3 Qatar
9.6.4 South Africa
9.6.5 Rest of Middle East & Africa
10 KEY DEVELOPMENTS
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies
11 COMPANY PROFILING
11.1 AbbVie Contract Manufacturing
11.2 AGC Biologics
11.3 Binex Co. Limited
11.4 Boehringer Ingelheim Group
11.5 Catalent Inc.
11.6 Fujifilm Diosynth Biotechnologies USA Inc.
11.7 JRS Pharma
11.8 Lonza Group
11.9 Parexel International Corporation
11.10 PRA Health Sciences
11.11 Rentschler Biotechnologies
11.12 Samsung Biologics
11.13 Sandoz Biopharmaceuticals (Novartis AG)
11.14 Toyobo Co. Limited
11.15 Wuxi Biologics
LIST OF TABLES
Table 1 Global Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Region (2019-2028) ($MN)
Table 2 Global Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Type (2019-2028) ($MN)
Table 3 Global Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Mammalian (2019-2028) ($MN)
Table 4 Global Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Non-mammalian (Microbial) (2019-2028) ($MN)
Table 5 Global Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Product (2019-2028) ($MN)
Table 6 Global Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Biologics (2019-2028) ($MN)
Table 7 Global Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Monoclonal (Diagnostic, Therapeutic, and Protein-based) (2019-2028) ($MN)
Table 8 Global Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Recombinant Proteins (2019-2028) ($MN)
Table 9 Global Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Antisense and Molecular Therapy (2019-2028) ($MN)
Table 10 Global Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Vaccines (2019-2028) ($MN)
Table 11 Global Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Other Biologics (2019-2028) ($MN)
Table 12 Global Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Biosimilars (2019-2028) ($MN)
Table 13 Global Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Service (2019-2028) ($MN)
Table 14 Global Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Contract Manufacturing Organization (CMO) (2019-2028) ($MN)
Table 15 Global Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Contract Research Organization (CRO) (2019-2028) ($MN)
Table 16 Global Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Application (2019-2028) ($MN)
Table 17 Global Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Big Pharma (2019-2028) ($MN)
Table 18 Global Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Generic Pharma (2019-2028) ($MN)
Table 19 Global Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Small Pharma (2019-2028) ($MN)
Table 20 North America Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Country (2019-2028) ($MN)
Table 21 North America Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Type (2019-2028) ($MN)
Table 22 North America Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Mammalian (2019-2028) ($MN)
Table 23 North America Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Non-mammalian (Microbial) (2019-2028) ($MN)
Table 24 North America Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Product (2019-2028) ($MN)
Table 25 North America Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Biologics (2019-2028) ($MN)
Table 26 North America Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Monoclonal (Diagnostic, Therapeutic, and Protein-based) (2019-2028) ($MN)
Table 27 North America Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Recombinant Proteins (2019-2028) ($MN)
Table 28 North America Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Antisense and Molecular Therapy (2019-2028) ($MN)
Table 29 North America Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Vaccines (2019-2028) ($MN)
Table 30 North America Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Other Biologics (2019-2028) ($MN)
Table 31 North America Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Biosimilars (2019-2028) ($MN)
Table 32 North America Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Service (2019-2028) ($MN)
Table 33 North America Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Contract Manufacturing Organization (CMO) (2019-2028) ($MN)
Table 34 North America Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Contract Research Organization (CRO) (2019-2028) ($MN)
Table 35 North America Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Application (2019-2028) ($MN)
Table 36 North America Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Big Pharma (2019-2028) ($MN)
Table 37 North America Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Generic Pharma (2019-2028) ($MN)
Table 38 North America Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Small Pharma (2019-2028) ($MN)
Table 39 Europe Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Country (2019-2028) ($MN)
Table 40 Europe Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Type (2019-2028) ($MN)
Table 41 Europe Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Mammalian (2019-2028) ($MN)
Table 42 Europe Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Non-mammalian (Microbial) (2019-2028) ($MN)
Table 43 Europe Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Product (2019-2028) ($MN)
Table 44 Europe Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Biologics (2019-2028) ($MN)
Table 45 Europe Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Monoclonal (Diagnostic, Therapeutic, and Protein-based) (2019-2028) ($MN)
Table 46 Europe Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Recombinant Proteins (2019-2028) ($MN)
Table 47 Europe Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Antisense and Molecular Therapy (2019-2028) ($MN)
Table 48 Europe Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Vaccines (2019-2028) ($MN)
Table 49 Europe Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Other Biologics (2019-2028) ($MN)
Table 50 Europe Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Biosimilars (2019-2028) ($MN)
Table 51 Europe Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Service (2019-2028) ($MN)
Table 52 Europe Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Contract Manufacturing Organization (CMO) (2019-2028) ($MN)
Table 53 Europe Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Contract Research Organization (CRO) (2019-2028) ($MN)
Table 54 Europe Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Application (2019-2028) ($MN)
Table 55 Europe Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Big Pharma (2019-2028) ($MN)
Table 56 Europe Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Generic Pharma (2019-2028) ($MN)
Table 57 Europe Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Small Pharma (2019-2028) ($MN)
Table 58 Asia Pacific Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Country (2019-2028) ($MN)
Table 59 Asia Pacific Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Type (2019-2028) ($MN)
Table 60 Asia Pacific Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Mammalian (2019-2028) ($MN)
Table 61 Asia Pacific Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Non-mammalian (Microbial) (2019-2028) ($MN)
Table 62 Asia Pacific Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Product (2019-2028) ($MN)
Table 63 Asia Pacific Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Biologics (2019-2028) ($MN)
Table 64 Asia Pacific Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Monoclonal (Diagnostic, Therapeutic, and Protein-based) (2019-2028) ($MN)
Table 65 Asia Pacific Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Recombinant Proteins (2019-2028) ($MN)
Table 66 Asia Pacific Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Antisense and Molecular Therapy (2019-2028) ($MN)
Table 67 Asia Pacific Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Vaccines (2019-2028) ($MN)
Table 68 Asia Pacific Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Other Biologics (2019-2028) ($MN)
Table 69 Asia Pacific Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Biosimilars (2019-2028) ($MN)
Table 70 Asia Pacific Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Service (2019-2028) ($MN)
Table 71 Asia Pacific Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Contract Manufacturing Organization (CMO) (2019-2028) ($MN)
Table 72 Asia Pacific Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Contract Research Organization (CRO) (2019-2028) ($MN)
Table 73 Asia Pacific Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Application (2019-2028) ($MN)
Table 74 Asia Pacific Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Big Pharma (2019-2028) ($MN)
Table 75 Asia Pacific Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Generic Pharma (2019-2028) ($MN)
Table 76 Asia Pacific Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Small Pharma (2019-2028) ($MN)
Table 77 South America Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Country (2019-2028) ($MN)
Table 78 South America Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Type (2019-2028) ($MN)
Table 79 South America Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Mammalian (2019-2028) ($MN)
Table 80 South America Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Non-mammalian (Microbial) (2019-2028) ($MN)
Table 81 South America Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Product (2019-2028) ($MN)
Table 82 South America Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Biologics (2019-2028) ($MN)
Table 83 South America Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Monoclonal (Diagnostic, Therapeutic, and Protein-based) (2019-2028) ($MN)
Table 84 South America Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Recombinant Proteins (2019-2028) ($MN)
Table 85 South America Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Antisense and Molecular Therapy (2019-2028) ($MN)
Table 86 South America Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Vaccines (2019-2028) ($MN)
Table 87 South America Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Other Biologics (2019-2028) ($MN)
Table 88 South America Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Biosimilars (2019-2028) ($MN)
Table 89 South America Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Service (2019-2028) ($MN)
Table 90 South America Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Contract Manufacturing Organization (CMO) (2019-2028) ($MN)
Table 91 South America Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Contract Research Organization (CRO) (2019-2028) ($MN)
Table 92 South America Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Application (2019-2028) ($MN)
Table 93 South America Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Big Pharma (2019-2028) ($MN)
Table 94 South America Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Generic Pharma (2019-2028) ($MN)
Table 95 South America Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Small Pharma (2019-2028) ($MN)
Table 96 Middle East & Africa Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Country (2019-2028) ($MN)
Table 97 Middle East & Africa Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Type (2019-2028) ($MN)
Table 98 Middle East & Africa Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Mammalian (2019-2028) ($MN)
Table 99 Middle East & Africa Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Non-mammalian (Microbial) (2019-2028) ($MN)
Table 100 Middle East & Africa Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Product (2019-2028) ($MN)
Table 101 Middle East & Africa Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Biologics (2019-2028) ($MN)
Table 102 Middle East & Africa Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Monoclonal (Diagnostic, Therapeutic, and Protein-based) (2019-2028) ($MN)
Table 103 Middle East & Africa Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Recombinant Proteins (2019-2028) ($MN)
Table 104 Middle East & Africa Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Antisense and Molecular Therapy (2019-2028) ($MN)
Table 105 Middle East & Africa Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Vaccines (2019-2028) ($MN)
Table 106 Middle East & Africa Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Other Biologics (2019-2028) ($MN)
Table 107 Middle East & Africa Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Biosimilars (2019-2028) ($MN)
Table 108 Middle East & Africa Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Service (2019-2028) ($MN)
Table 109 Middle East & Africa Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Contract Manufacturing Organization (CMO) (2019-2028) ($MN)
Table 110 Middle East & Africa Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Contract Research Organization (CRO) (2019-2028) ($MN)
Table 111 Middle East & Africa Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Application (2019-2028) ($MN)
Table 112 Middle East & Africa Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Big Pharma (2019-2028) ($MN)
Table 113 Middle East & Africa Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Generic Pharma (2019-2028) ($MN)
Table 114 Middle East & Africa Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Small Pharma (2019-2028) ($MN)
Table 1 Global Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Region (2019-2028) ($MN)
Table 2 Global Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Type (2019-2028) ($MN)
Table 3 Global Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Mammalian (2019-2028) ($MN)
Table 4 Global Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Non-mammalian (Microbial) (2019-2028) ($MN)
Table 5 Global Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Product (2019-2028) ($MN)
Table 6 Global Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Biologics (2019-2028) ($MN)
Table 7 Global Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Monoclonal (Diagnostic, Therapeutic, and Protein-based) (2019-2028) ($MN)
Table 8 Global Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Recombinant Proteins (2019-2028) ($MN)
Table 9 Global Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Antisense and Molecular Therapy (2019-2028) ($MN)
Table 10 Global Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Vaccines (2019-2028) ($MN)
Table 11 Global Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Other Biologics (2019-2028) ($MN)
Table 12 Global Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Biosimilars (2019-2028) ($MN)
Table 13 Global Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Service (2019-2028) ($MN)
Table 14 Global Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Contract Manufacturing Organization (CMO) (2019-2028) ($MN)
Table 15 Global Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Contract Research Organization (CRO) (2019-2028) ($MN)
Table 16 Global Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Application (2019-2028) ($MN)
Table 17 Global Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Big Pharma (2019-2028) ($MN)
Table 18 Global Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Generic Pharma (2019-2028) ($MN)
Table 19 Global Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Small Pharma (2019-2028) ($MN)
Table 20 North America Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Country (2019-2028) ($MN)
Table 21 North America Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Type (2019-2028) ($MN)
Table 22 North America Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Mammalian (2019-2028) ($MN)
Table 23 North America Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Non-mammalian (Microbial) (2019-2028) ($MN)
Table 24 North America Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Product (2019-2028) ($MN)
Table 25 North America Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Biologics (2019-2028) ($MN)
Table 26 North America Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Monoclonal (Diagnostic, Therapeutic, and Protein-based) (2019-2028) ($MN)
Table 27 North America Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Recombinant Proteins (2019-2028) ($MN)
Table 28 North America Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Antisense and Molecular Therapy (2019-2028) ($MN)
Table 29 North America Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Vaccines (2019-2028) ($MN)
Table 30 North America Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Other Biologics (2019-2028) ($MN)
Table 31 North America Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Biosimilars (2019-2028) ($MN)
Table 32 North America Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Service (2019-2028) ($MN)
Table 33 North America Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Contract Manufacturing Organization (CMO) (2019-2028) ($MN)
Table 34 North America Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Contract Research Organization (CRO) (2019-2028) ($MN)
Table 35 North America Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Application (2019-2028) ($MN)
Table 36 North America Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Big Pharma (2019-2028) ($MN)
Table 37 North America Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Generic Pharma (2019-2028) ($MN)
Table 38 North America Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Small Pharma (2019-2028) ($MN)
Table 39 Europe Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Country (2019-2028) ($MN)
Table 40 Europe Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Type (2019-2028) ($MN)
Table 41 Europe Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Mammalian (2019-2028) ($MN)
Table 42 Europe Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Non-mammalian (Microbial) (2019-2028) ($MN)
Table 43 Europe Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Product (2019-2028) ($MN)
Table 44 Europe Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Biologics (2019-2028) ($MN)
Table 45 Europe Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Monoclonal (Diagnostic, Therapeutic, and Protein-based) (2019-2028) ($MN)
Table 46 Europe Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Recombinant Proteins (2019-2028) ($MN)
Table 47 Europe Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Antisense and Molecular Therapy (2019-2028) ($MN)
Table 48 Europe Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Vaccines (2019-2028) ($MN)
Table 49 Europe Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Other Biologics (2019-2028) ($MN)
Table 50 Europe Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Biosimilars (2019-2028) ($MN)
Table 51 Europe Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Service (2019-2028) ($MN)
Table 52 Europe Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Contract Manufacturing Organization (CMO) (2019-2028) ($MN)
Table 53 Europe Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Contract Research Organization (CRO) (2019-2028) ($MN)
Table 54 Europe Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Application (2019-2028) ($MN)
Table 55 Europe Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Big Pharma (2019-2028) ($MN)
Table 56 Europe Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Generic Pharma (2019-2028) ($MN)
Table 57 Europe Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Small Pharma (2019-2028) ($MN)
Table 58 Asia Pacific Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Country (2019-2028) ($MN)
Table 59 Asia Pacific Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Type (2019-2028) ($MN)
Table 60 Asia Pacific Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Mammalian (2019-2028) ($MN)
Table 61 Asia Pacific Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Non-mammalian (Microbial) (2019-2028) ($MN)
Table 62 Asia Pacific Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Product (2019-2028) ($MN)
Table 63 Asia Pacific Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Biologics (2019-2028) ($MN)
Table 64 Asia Pacific Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Monoclonal (Diagnostic, Therapeutic, and Protein-based) (2019-2028) ($MN)
Table 65 Asia Pacific Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Recombinant Proteins (2019-2028) ($MN)
Table 66 Asia Pacific Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Antisense and Molecular Therapy (2019-2028) ($MN)
Table 67 Asia Pacific Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Vaccines (2019-2028) ($MN)
Table 68 Asia Pacific Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Other Biologics (2019-2028) ($MN)
Table 69 Asia Pacific Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Biosimilars (2019-2028) ($MN)
Table 70 Asia Pacific Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Service (2019-2028) ($MN)
Table 71 Asia Pacific Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Contract Manufacturing Organization (CMO) (2019-2028) ($MN)
Table 72 Asia Pacific Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Contract Research Organization (CRO) (2019-2028) ($MN)
Table 73 Asia Pacific Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Application (2019-2028) ($MN)
Table 74 Asia Pacific Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Big Pharma (2019-2028) ($MN)
Table 75 Asia Pacific Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Generic Pharma (2019-2028) ($MN)
Table 76 Asia Pacific Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Small Pharma (2019-2028) ($MN)
Table 77 South America Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Country (2019-2028) ($MN)
Table 78 South America Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Type (2019-2028) ($MN)
Table 79 South America Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Mammalian (2019-2028) ($MN)
Table 80 South America Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Non-mammalian (Microbial) (2019-2028) ($MN)
Table 81 South America Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Product (2019-2028) ($MN)
Table 82 South America Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Biologics (2019-2028) ($MN)
Table 83 South America Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Monoclonal (Diagnostic, Therapeutic, and Protein-based) (2019-2028) ($MN)
Table 84 South America Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Recombinant Proteins (2019-2028) ($MN)
Table 85 South America Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Antisense and Molecular Therapy (2019-2028) ($MN)
Table 86 South America Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Vaccines (2019-2028) ($MN)
Table 87 South America Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Other Biologics (2019-2028) ($MN)
Table 88 South America Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Biosimilars (2019-2028) ($MN)
Table 89 South America Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Service (2019-2028) ($MN)
Table 90 South America Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Contract Manufacturing Organization (CMO) (2019-2028) ($MN)
Table 91 South America Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Contract Research Organization (CRO) (2019-2028) ($MN)
Table 92 South America Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Application (2019-2028) ($MN)
Table 93 South America Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Big Pharma (2019-2028) ($MN)
Table 94 South America Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Generic Pharma (2019-2028) ($MN)
Table 95 South America Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Small Pharma (2019-2028) ($MN)
Table 96 Middle East & Africa Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Country (2019-2028) ($MN)
Table 97 Middle East & Africa Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Type (2019-2028) ($MN)
Table 98 Middle East & Africa Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Mammalian (2019-2028) ($MN)
Table 99 Middle East & Africa Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Non-mammalian (Microbial) (2019-2028) ($MN)
Table 100 Middle East & Africa Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Product (2019-2028) ($MN)
Table 101 Middle East & Africa Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Biologics (2019-2028) ($MN)
Table 102 Middle East & Africa Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Monoclonal (Diagnostic, Therapeutic, and Protein-based) (2019-2028) ($MN)
Table 103 Middle East & Africa Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Recombinant Proteins (2019-2028) ($MN)
Table 104 Middle East & Africa Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Antisense and Molecular Therapy (2019-2028) ($MN)
Table 105 Middle East & Africa Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Vaccines (2019-2028) ($MN)
Table 106 Middle East & Africa Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Other Biologics (2019-2028) ($MN)
Table 107 Middle East & Africa Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Biosimilars (2019-2028) ($MN)
Table 108 Middle East & Africa Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Service (2019-2028) ($MN)
Table 109 Middle East & Africa Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Contract Manufacturing Organization (CMO) (2019-2028) ($MN)
Table 110 Middle East & Africa Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Contract Research Organization (CRO) (2019-2028) ($MN)
Table 111 Middle East & Africa Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Application (2019-2028) ($MN)
Table 112 Middle East & Africa Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Big Pharma (2019-2028) ($MN)
Table 113 Middle East & Africa Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Generic Pharma (2019-2028) ($MN)
Table 114 Middle East & Africa Biologics Contract Development and Manufacturing Organization (CDMO) Market Outlook, By Small Pharma (2019-2028) ($MN)
